2型糖尿病伴或不伴心血管疾病患者临床特征与心脏骤停的关联:基于常规初级保健数据的纵向病例对照研究
该研究基于荷兰ARREST登记和初级保健数据,纳入689例心脏骤停病例和3230例对照,分析2型糖尿病患者临床特征与心脏骤停的纵向关联。多变量模型显示低空腹血糖、降压药、降糖药、心力衰竭及延长QTc的胃动力药、抗生素、抗精神病药与心脏骤停相关。亚组分析提示抗生素和抗精神病药仅在无心血管疾病者中与心脏骤停相关。
要点
- 低空腹血糖(<4.5 mmol/mol)、降压药、降糖药(口服/胰岛素/两者联用)与心脏骤停风险相关。
- 心力衰竭史及延长QTc的胃动力药、抗生素、抗精神病药与心脏骤停风险相关。
- 延长QTc的抗生素和抗精神病药仅在无心血管疾病者中与心脏骤停相关。
核心结论
- 在2型糖尿病患者中,低空腹血糖、使用延长QTc的胃动力药、抗生素或抗精神病药以及心力衰竭史与心脏骤停风险相关。
- 亚组分析表明,抗生素和抗精神病药的使用特别增加无心血管疾病者的心脏骤停风险。
研究设计与样本
- 病例对照研究,病例为2010-2020年荷兰Noord-Holland地区ARREST登记中院外复苏尝试的2型糖尿病心脏骤停患者,对照为按年龄、性别、2型糖尿病和全科医生诊所匹配的最多5名非心脏骤停者。
- 从全科医生电子健康记录中收集临床测量、用药和病史,使用多变量时间依赖Cox回归分析总样本及有无心血管疾病亚组。
- 共纳入689例心脏骤停病例和3230例非心脏骤停对照。
主要发现
- 总样本中,低空腹血糖(<4.5 mmol/mol)的风险比为1.91(95%CI 1.00-3.64),降压药为1.80(1.39-2.33),仅口服降糖药为1.32(1.06-1.63),仅胰岛素为2.31(1.71-3.12),口服联合胰岛素为1.64(1.21-2.22)。
- 总样本中,心力衰竭为1.91(1.55-2.35),延长QTc的胃动力药为1.78(1.27-2.50),抗生素为1.35(1.05-1.73),抗精神病药为2.10(1.42-3.09)。
- 亚组效应修饰分析中,延长QTc的抗生素(1.82 [1.26-2.63])和抗精神病药(3.10 [2.09-4.59])仅在无心血管疾病者中与心脏骤停相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess longitudinal associations with sudden cardiac arrest (SCA) of clinical characteristics recorded in primary care in people with type 2 diabetes (T2D), both with and without cardiovascular disease (CVD). RESEARCH DESIGN AND METHODS: We performed a case-control study, with SCA case subjects with T2D from the Amsterdam Resuscitation Studies (ARREST) registry of out-of-hospital resuscitation attempts in the Dutch Noord-Holland region (2010-2020) and up to five matched (age, sex, T2D, general practitioner [GP] practice) non-SCA control subjects. We collected relevant clinical measurements, medication use, and medical history from GPs' electronic health care records. We analyzed the associations of clinical characteristics and medication use with SCA in the total sample and in subgroups with or without CVD using multivariable time-dependent Cox regression (hazard ratios, 95% confidence intervals). RESULTS: We included 689 SCA case subjects and 3,230 non-SCA control subjects. In multivariable models, low fasting glucose (<4.5 mmol/mol: 1.91 [1.00-3.64]), antihypertensive (1.80 [1.39-2.33]), glucose lowering (oral only: 1.32 [1.06-1.63]; insulin only: 2.31 [1.71-3.12]; oral and insulin: 1.64 [1.21-2.22]), heart failure (1.91 [1.55-2.35]), and QTc-prolonging prokinetic (1.78 [1.27-2.50]), antibiotic (1.35 [1.05-1.73]), and antipsychotic (2.10 [1.42-3.09]) medication were associated with SCA in the total sample. In subgroup effect modification analyses, QTc-prolonging antibiotic (1.82 [1.26-2.63]) and antipsychotic (3.10 [2.09-4.59]) medication use were associated with SCA only in those without CVD. CONCLUSIONS: In people with T2D, low fasting glucose and QTc-prolonging prokinetic, antibiotic, or antipsychotic medication use and a history of heart failure are associated with SCA risk. Subgroup analyses indicate antibiotic and antipsychotic medication use increases SCA risk specifically in those without CVD.
引用
- Harms PP, van Dongen LH, Bennis F, et al. Associations of Clinical Characteristics With Sudden Cardiac Arrest in People With Type 2 Diabetes With and Without Cardiovascular Disease: A Longitudinal Case-Control Study Using Routine Primary Care Data. Diabetes Care. 2025. PMID: 39556475. doi:10.2337/dc24-0715
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。